{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:55:45Z","timestamp":1790920545570,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to develop and validate a clinically applicable diagnostic predictive model to facilitate early identification of severe\n                      <jats:italic>Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (SMPP) within 24\u2005h of admission.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data from children with MPP hospitalized from January 2023 to December 2023, were retrospectively collected as the training set. Patients were classified into general MPP (GMPP) or SMPP groups based on whether SMPP occurred within 24\u2005h of admission. After comparing the differences in clinical data between the two groups at admission, multivariate logistic regression was used to identify risk indicators for SMPP and construct a diagnostic predictive model. A nomogram was developed to visualize the model. Subsequently, data from children with MPP hospitalized between January 2024 and December 2024 were collected to conduct temporal external validation of the model. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curves, Hosmer-Lemeshow goodness-of-fit test, calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 412 children with MPP were included, with 222 cases within the training set (119 SMPP, 53.60%) and 190 within the temporal external validation set (129 SMPP, 67.89%). Independent risk indicators for the occurrence of SMPP included the duration of fever before admission (OR\u2009=\u20092.019, 95% CI: 1.387\u20132.938), shortness of breath (OR\u2009=\u2009111.599, 95% CI: 11.512\u20131,081.834), unresponsive to macrolide before admission (OR\u2009=\u20093.687, 95% CI: 1.529\u20138.892), interleukin-6 (IL-6) (OR\u2009=\u20091.052, 95% CI: 1.010\u20131.095), and pulmonary consolidation (OR\u2009=\u200931.634, 95% CI: 11.643\u201385.948) (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). The nomogram based on the five aforementioned variables demonstrated favorable discriminative performance, with areas under the ROC curve (AUC) of 0.916 (95% CI: 0.880\u20130.951) within the training set, 0.907 (95% CI: 0.873\u20130.946) within the internal validation, and 0.817 (95% CI: 0.758\u20130.876) within the temporal external validation set. The calibration curve and Hosmer-Lemeshow goodness-of-fit test showed that the model had good calibration. Both the DCA and CIC demonstrated favorable clinical utility of the model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The model developed in this study provides valuable reference for early risk stratification of pediatric SMPP and timely, individualized clinical decision-making in children with MPP. However, extensive external validation is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1927137","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:37:52Z","timestamp":1790919472000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a nomogram for stratifying severe Mycoplasma pneumoniae pneumonia risk in children early"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhongying","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Second People's Hospital of Futian District","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wugao","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Second People's Hospital of Futian District","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Second People's Hospital of Futian District","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12879-025-10657-4","article-title":"Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany","volume":"25","author":"Waldeck","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13052-025-01846-7","article-title":"Mycoplasma pneumoniae detections in children with acute respiratory infection, 2010-2023: a large sample study in China","volume":"51","author":"Miao","year":"2025","journal-title":"Ital J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0288824","DOI":"10.1128\/spectrum.02888-24","article-title":"Changes in Mycoplasma pneumoniae epidemiological and clinical features in children before, during, and after the COVID-19 pandemic in Shanghai, China","volume":"13","author":"Huang","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101103","DOI":"10.1016\/j.lanepe.2024.101103","article-title":"Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort study","volume":"47","author":"Dungu","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00431-025-06326-y","article-title":"Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study","volume":"184","author":"Robinson","year":"2025","journal-title":"Eur J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"piae132","DOI":"10.1093\/jpids\/piae132","article-title":"Increasing number of clinically severe Mycoplasma pneumoniae infections in children after the COVID-19 pandemic: a single-center case series","volume":"14","author":"McCarthy","year":"2025","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/inf.0000000000004461","article-title":"Increased severity of Mycoplasma pneumoniae infections in Spanish children","volume":"43","author":"M\u00e9ndez-Echevarr\u00eda","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"piae119","DOI":"10.1093\/jpids\/piae119","article-title":"Resurgence of pediatric Mycoplasma pneumoniae infections in southeast Texas, November 2023-June 2024","volume":"14","author":"Danner","year":"2025","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13052-025-02064-x","article-title":"Shifting epidemic trends and severity in pediatric Mycoplasma pneumoniae infections in the post-COVID-19 era","volume":"51","author":"Yang","year":"2025","journal-title":"Ital J Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s10096-025-05215-4","article-title":"Clinical features and risk factors for severe macrolide-resistant Mycoplasma pneumoniae pneumonia induced by 23 S rRNA A2063G mutation: a retrospective observational study","volume":"44","author":"Ding","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13052-025-02039-y","article-title":"Prediction model for severe Mycoplasma pneumoniae pneumonia and analysis of macrolide-resistance in children: a case-control study","volume":"51","author":"Liu","year":"2025","journal-title":"Ital J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2147\/jir.S447569","article-title":"Construction and validation of a nomogram model to predict the severity of Mycoplasma pneumoniae pneumonia in children","volume":"17","author":"Li","year":"2024","journal-title":"J Inflamm Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/s41598-024-58784-3","article-title":"A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13052-025-02006-7","article-title":"Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia","volume":"51","author":"Li","year":"2025","journal-title":"Ital J Pediatr"},{"key":"B15","first-page":"79","article-title":"Guidelines for diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023 edition)","volume":"50","year":"2023","journal-title":"Int J Epidemiol Infect Dis"},{"key":"B16","year":""},{"key":"B17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1186\/s12879-025-11584-0","article-title":"Clinical characteristics of Mycoplasma pneumoniae pneumonia in children with 23 S rRNA mutations in domain V and exploration of the timing of glucocorticoid therapy","volume":"25","author":"Shen","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3760\/cma.j.issn.1674-2397.2019.01.002","article-title":"Guideline for diagnosis and treatment of community-acquired pneumonia in children (2019 version)","volume":"12","year":"2019","journal-title":"Chin J Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","article-title":"Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae","volume":"7","author":"Yamazaki","year":"2016","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"107480","DOI":"10.1016\/j.rmed.2023.107480","article-title":"Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes","volume":"221","author":"Huang","year":"2024","journal-title":"Respir Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3390\/microorganisms13051152","article-title":"The clinical profile of pediatric M. pneumoniae infections in the context of a new post-pandemic wave","volume":"13","author":"Meri\u0219escu","year":"2025","journal-title":"Microorganisms"},{"key":"B22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12879-024-09340-x","article-title":"A comparative study of general and severe Mycoplasma pneumoniae pneumonia in children","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1489389","DOI":"10.3389\/fped.2024.1489389","article-title":"Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study","volume":"12","author":"Li","year":"2024","journal-title":"Front Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1585042","DOI":"10.3389\/fpubh.2025.1585042","article-title":"Building a diagnostic prediction model for severe Mycoplasma pneumoniae pneumonia in children using machine learning","volume":"13","author":"Gong","year":"2025","journal-title":"Front Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.21037\/qims-22-508","article-title":"Multidimensional analysis using low-dose computed tomography to evaluate the severity of Mycoplasma pneumoniae pneumonia in children","volume":"13","author":"Chu","year":"2023","journal-title":"Quant Imaging Med Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12938-025-01410-8","article-title":"Prediction of risk factors of plastic bronchitis in children with severe Mycoplasma pneumoniae pneumonia","volume":"24","author":"Mu","year":"2025","journal-title":"Biomed Eng Online"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.2147\/idr.S387890","article-title":"A lung ultrasound-based nomogram for the prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children","volume":"15","author":"Liu","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B28","doi-asserted-by":"publisher","first-page":"18875","DOI":"10.5826\/tuj.2026.18875","article-title":"Modified lung ultrasound score and related findings in children with Mycoplasma pneumoniae pneumonia","volume":"18","author":"Xie","year":"2026","journal-title":"Ultrasound J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielp\u00fctz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/mrm.28985","article-title":"Protocols for multi-site trials using hyperpolarized (129) Xe MRI for imaging of ventilation, alveolar-airspace size, and gas exchange: a position paper from the (129) Xe MRI clinical trials consortium","volume":"86","author":"Niedbalski","year":"2021","journal-title":"Magn Reson Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1007\/s00330-024-10800-w","article-title":"Assessment of pulmonary physiological changes caused by aging, cigarette smoking, and COPD with hyperpolarized (129)Xe magnetic resonance","volume":"34","author":"Rao","year":"2024","journal-title":"Eur Radiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1164\/rccm.202203-0606OC","article-title":"Image phenotyping of preterm-born children using hyperpolarized (129)Xe lung magnetic resonance imaging and multiple-breath washout","volume":"207","author":"Chan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/jmri.28136","article-title":"Pediatric (129) Xe gas-transfer MRI-feasibility and applicability","volume":"56","author":"Willmering","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/jmri.29669","article-title":"Pulmonary MRI in newborns and children","volume":"61","author":"Stewart","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1021\/acs.jpca.4c08800","article-title":"Parahydrogen-hyperpolarized propane-d(6) gas contrast agent: t(1) relaxation dynamics and pilot millimeter-scale ventilation MRI","volume":"129","author":"Ariyasingha","year":"2025","journal-title":"J Phys Chem A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1021\/cbmi.4c00041","article-title":"Developing hyperpolarized butane gas for ventilation lung imaging","volume":"2","author":"Ariyasingha","year":"2024","journal-title":"Chem Biomed Imaging"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","article-title":"Current status of Mycoplasma pneumoniae infection in China","volume":"20","author":"Yan","year":"2024","journal-title":"World J Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1927137\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:37:53Z","timestamp":1790919473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1927137\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":37,"alternative-id":["10.3389\/fped.2026.1927137"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1927137","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1927137"}}